Abstract. Preclinical studies have suggested that paracrine factors from adipose-derived stem cells (ASCs) promote the healing of chronic wounds, and that the exposure of ASCs to hypoxia enhances their wound healing effect. To aid the translation of these findings into clinical use, robust wound models are necessary to explore each aspect of wound healing. The aspect of re-epithelization is often studied in a scratch assay based on transformed keratinocytes. However, there are concerns regarding the validity of this model, since these cell lines differ from normal keratinocytes, both in terms of proliferative capacity and differentiation, and sensitivity to environmental cues. In this study, the main challenge of using primary keratinocytes to examine the effects of ASCs was identified to be their different requirements for calcium in the culture media. We confirmed that a high calcium content led to morphological and cytoskeletal changes in primary keratinocytes, and demonstrated that a low calcium content compromised the growth of ASCs. We found that it is possible to perform the wound healing assay with primary keratinocytes, if the conditioned media from the ASCs is dialyzed to reduce the calcium concentration. Additionally, using this model of re-epithelization, conditioned media from normoxic ASCs was shown to markedly increase the rate of wound closure by primary keratinocytes, and this effect was significantly enhanced with media from the hypoxia-exposed ASCs. These findings, which are in line with the observations from previous in vivo studies, highlight the validity of this modified assay to investigate the wound healing properties of ASCs in vitro.
Introduction
It has been proposed that adipose-derived stem cells (ASCs) can be used for the treatment of chronic wounds (1) . Several preclinical studies have demonstrated that ASCs secrete soluble factors that promote angiogenesis and keratinocyte re-epithelization, and protect against apoptosis (2) (3) (4) . Furthermore, studies have demonstrated that the culture of ASCs under hypoxic conditions enhances their angiogenic properties (2, 5) ; however, the mechanisms through which hypoxia modulates the ASC properties relevant to re-epithelialization have not yet been fully elucidated.
A commonly used in vitro model to assess wound healing is the scratch assay, which is based on creating a small scratch in a confluent monolayer cell culture and monitoring the closure of the scratch by migration/growth of the cells (Fig. 1A) . To mimic the wound healing process of cutaneous wounds, keratinocytes are the most relevant cells, as re-epithelization steps include sequential keratinocyte proliferation, migration and differentiation converging in stratification (6) .
Previously, when assessing the wound healing effect of ASCs and other mesenchymal stem cells on keratinocytes in a scratch assay, a combination of conditioned media from stem cells and the spontaneously transformed aneuploid immortal keratinocyte cell line, HaCaT, has often been preferred (3, 7, 8) . However, as transformed cells often display an altered response to growth factors and cytokines compared to their non-cancerous counterparts (9) , and may respond in a hyperactive manner to hypoxia-induced factors, such as epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) (9) (10) (11) , this cell line may not be the best option to predict in vivo responses. Another difference between primary keratinocytes and the HaCaT cell line is that primary keratinocytes are sensitive to calcium concentrations >90 µM (12) , which induces differentiation and the cessation of proliferation, Hypoxia enhances the wound-healing potential of adipose-derived stem cells in a novel human primary keratinocyte-based scratch assay (14) . In this study, we describe how the ASC-keratinocyte scratch assay can be modified to better mimic in vivo re-epithelialization. This modification entails dialysis of conditioned media from ASCs prior to testing on primary keratinocytes. Furthermore, we demonstrate that the modified assay can be used to explore the effects of hypoxia on the wound healing properties of ASCs.
Materials and methods
Cell culture. Human primary keratinocytes from three donors; HEKa lot #1249380, HEKa lot #1352914, HEKn lot #1030422 (Thermo Fisher Scientific, Frederick, MD, USA) were used for all the experiments. They were maintained in EpiLife, composed of EpiLife ® basal medium (Gibco™/Thermo Fisher Scientific, Taastrup, Denmark) supplemented with 1X Human Keratinocyte Growth Supplement (Gibco™/ Thermo Fisher Scientific), 100 U/ml penicillin, 0.1 mg/ ml streptomycin (Invitrogen™/Thermo Fisher Scientific, Taastrup, Denmark). The keratinocytes were maintained as prescribed by the manufacturer, and cultured on tissue culture polystyrene (TCP) flasks (Greiner Bio-One, Fredensborg, Denmark) coated with Coating Matrix kit. For subcultivation, TrypLE™ (both from Gibco/Thermo Fisher Scientific) was used.
The ASCs used in this study (ASC21) have previously been isolated and extensively characterized in our laboratory (2, (15) (16) (17) (18) (19) . The cells were obtained from the adipose tissue of a healthy donor using a protocol that was approved by the Regional Committee on Biomedical Research Ethics of Northern Jutland, Denmark (project no. VN 2005/54). The ASCs were cultured in StemPro, composed of StemPro ® MSC SFM XenoFree (Gibco/Thermo Fisher Scientific) supplemented with 200 mM L-glutamine and 100 U/ml penicillin, 0.1 mg/ml streptomycin (both from Gibco/Thermo Fisher Scientific) and cultured on cultured on TCP flasks (Greiner Bio-One), which were coated with CellStart™ CTS™ according to the manufacturer instructions. For subcultivation, TrypLE™ (both from Gibco/Thermo Fisher Scientific) was used.
Comparison of ASC and keratinocyte morphology and growth with varying concentrations of calcium. To compare the effects of the different calcium concentrations in EpiLife and StemPro on keratinocytes and ASCs, the cells were seeded at a density of 50,000 and 8,000 cells/cm 2 , respectively in 96-well plates and cultured until 80% confluent. At this point, the cells were washed with phosphate-buffered saline (PBS; Gibco™/Thermo Fisher Scientific) and supplied with either EpiLife, EpiLife with increasing levels of CaCl 2 from 60 µM to 2 mM, or StemPro, and incubated for 24 h. To assess cell morphology and cell number, the cells were washed with PBS and fixed in 4% formaldehyde, stained with Hoechst 33342 (1 µg/ml; Molecular Probes ® , Eugene, OR, USA), permeabilized using 0.1% Triton X-100 (Sigma-Aldrich), and stained with BODIPY ® 558/568 phalloidin (1:40; Molecular Probes). The stained cells were kept in PBS at 4˚C until analysis. Fluorescence images were obtained using the AxioVision software package with a Zeiss AxioObserver.Z1 microscope equipped with an AxioCam MRm camera and a motorized stage (Carl Zeiss, Oberkochen, Germany). To quantify the cell number, the number of nuclei was counted using ImageJ 1.47v (National Institutes of Health, Bethesda, MD, USA).
To evaluate the effect on keratinocytes of lowering the calcium concentration of StemPro, the medium was dialyzed against EpiLife basal medium. For dialysis, 10 ml StemPro were injected into a Slide-A-Lyzer Dialysis Cassette, 2 MWCO (Pierce™/Thermo Fisher Scientific) and dialyzed in 1.25 liters EpiLife at 4˚C for 2 h after which the EpiLife was exchanged with new EpiLife (1.25 liters) for continuing dialysis overnight. After dialysis, the low-calcium StemPro was tested on keratinocyte morphology as described above.
Effect of combining EpiLife and StemPro on keratinocyte morphology.
To determine whether diluting StemPro into EpiLife improves the compatibility with keratinocytes, different ratios of EpiLife vs. StemPro were tested on the keratinocytes. The keratinocytes were seeded at 20,000 cells/ cm 2 in 96-well plates and incubated overnight, after which, the cells were washed with PBS and cultured for 24 h in either EpiLife, StemPro, or EpiLife and StemPro at the ratios 3:1, 1:1 and 1:3. The morphology of the cells was evaluated by phase contrast using the IncuCyte ZOOM ® system (Essen BioScience, Hertfordshire, UK) and IncuCyte™ High Definition Imaging Mode.
To evaluate whether EpiLife supplemented with the protein fraction from conditioned StemPro supports normal keratinocyte morphology, conditioned StemPro was concentrated in 3,000 NMWL Amicon Ultra-15 centrifugal filter units (Merck Millipore, Darmstadt, Germany) and reconstituted in EpiLife to 50, 75 or 100% of the original concentration and tested on the keratinocytes as described above.
Preparation of conditioned media. For the production of conditioned media, the ASCs were seeded in T175 culture flasks at a density of 8,000 cells/cm 2 , and incubated in a standard incubator at 37˚C, 20% O 2 , 5% CO 2 . When the cells were 80% confluent, they were washed twice in PBS and 30 ml fresh StemPro were added to each flask. Half of the flasks were left in the standard incubator for normoxic conditioning of the media and the other half were transferred to a BioSpherix clove box (Xvivo; BioSpherix, Redfield, NY, USA) and cultured at 37˚C, 1% O 2 , 5% CO 2 for hypoxic conditioning. After 24 h of incubation the media were harvested, centrifuged to pellet debris, and the supernatant kept at -80˚C until further analysis.
Scratch assay. To investigate the wound healing effect of ASCs on human primary keratinocytes, the keratinocytes were seeded with 50,000 cells/cm 2 in 24-or 96-well plates. When the cells formed a confluent monolayer, they were scratched using the Wounding Pin Tool (V&P Scientific, Inc., San Diego, CA, USA) or the WoundMaker™ (Essen BioScience) and washed in PBS to remove cell debris. StemPro, dialyzed StemPro, conditioned StemPro, dialyzed normoxic/hypoxic conditioned StemPro, or EpiLife were added to the cells (Fig. 1B) . Wound healing was monitored by time-lapse photography taking images every hour using a PeCon Incubator system including a CTI-controller 3700 digital and a Tempcontrol 37-2 digital, connected to an AxioVision software package with a Zeiss AxioObserver.Z1 microscope equipped with an AxioCam MRm camera and a motorized stage (Carl Zeiss) or using the IncuCyte ZOOM ® system (Essen BioScience). The relative wound size at each time point was analyzed using the TScratch software (20) or the IncuCyte™ Scratch Wound Cell Migration Software Module (Essen BioScience). The media was tested on three primary keratinocyte cultures in two separate experiments (n=6), each in technical triplicates.
Statistical analysis. Statistical analysis was performed using SigmaPlot 12.0 (Systat Software, Erkrath, Germany). The normal distribution of each group was assessed by means of the Shapiro-Wilk test. Additionally, variance was tested using an Equal Variance test. Data are presented as the mean ± standard error of the mean (SEM). A p-value <0.05 was considered to indicate a statistically significant difference. For the comparison of two groups, a paired t-test was used. For the comparison of more than two groups, a one-way repeated measures analysis of variance (ANOVA) with Bonferroni's post hoc test was used.
Results

Comparison of the effect of varying calcium concentrations on the morphology and growth of keratinocytes and ASCs.
EpiLife and StemPro were evaluated for their compatibility for the culture of both cell types ( Fig. 2A) . It was evident that the keratinocytes cultured in StemPro lost the typical cobblestone-like appearance of basal keratinocytes and displayed a more mature phenotype with morphology and rearranged cytoskeleton with cortical actin bundles resembling those of differentiated keratinocytes (21) . On the other hand, the ASCs retained their morphology when cultured in EpiLife; however, since the number of cells after 24 h in EpiLife was significantly lower than that in StemPro, it suggested that the growth conditions were sub-optimal. To confirm that these observations were a result of the cellular response to differences in calcium concentrations, we performed a calcium dose escalation experiment with EpiLife medium. For the keratinocytes, a gradual change in cell morphology and cytoskeleton pattern was observed with the increasing calcium concentrations already after 24 h (Fig. 2B) . The cells appeared more clustered and the actin fibers were more diffuse. These morphological changes were slightly noticeable when 120 µM calcium were supplemented to the media, and were obviously prominent at concentrations of 480 µM and above. No apparent morphological or cytoskeletal effects of changing the calcium concentration were observed for the ASCs. Despite the dramatic effects on keratinocyte morphology, changes in the calcium concentration did not affect cell numbers during short-term exposure (Fig. 2C) . This is in sharp contrast to the ASCs, where the use of EpiLife decreased the cell number. This inhibition was attenuated by supplementing EpiLife with calcium in the range of 860 µM to 1.4 mM (Fig. 2D) .
Development of keratinocyte-compatible media based on
StemPro. To circumvent the media incompatibility issue, we cultured ASCs in StemPro for the production of conditioned media. Consequently, for the subsequent use of conditioned media on keratinocytes, we evaluated different methods to reduce the calcium concentration while maintaining the ASC secreted proteins.
A simple solution of culturing the keratinocytes at 3:1, 1:1 and 1:3 ratios of EpiLife to StemPro was tested (Fig. 3A) . The evaluation of the morphology revealed that even in the highest dilution of StemPro (with approximately 300 µM of calcium), the cultures revealed the presence of clustered keratinocytes, which had lost their cobblestone appearance.
Another method tested was concentrating the protein fraction of StemPro using spin filter columns and afterwards resuspending it in EpiLife in volumes, such that the concentration of proteins derived from StemPro were 50, 75 and 100% of the original (Fig. 3B) . The cells did not display the morphology associated with a high calcium content; however, the cells appeared more round and smaller. In particular, the cells grown in the highest concentration of protein detached before a scratch assay could be completed (data not shown).
The effect of dialyzing StemPro in EpiLife prior to the culture of keratinocytes was examined. We observed that the morphology of the keratinocytes cultured in dialyzed StemPro closely resembled that of cells grown in EpiLife (Fig. 3C , Figure 1 . Schematic overview of the scratch assay and the production, preparation and functional testing of conditioned media. (A) Human primary keratinocytes were cultured until confluent in EpiLife, whereupon a pin tool was used to apply a uniform scratch. The medium was replaced with conditioned medium and the process of wound closure monitored to assess the degree of wound healing. (B) To produce conditioned media, StemPro was added to near-confluent adipose-derived stem cell (ASC) cultures. After 24 h, the conditioned StemPro was collected for downstream processing and application in the scratch assay. The data from the EpiLife-based media were compared to those from StemPro using a one-way ANOVA followed by a multiple comparisons vs. control, * p<0.05, ** p<0.01 and *** p<0.001.
upper panel). Additionally, the visualization of the cytoskeleton revealed that StemPro induced a more peripheral arrangement of the actin fibers, and that this to a high degree was avoided by using dialyzed StemPro that maintained the diffuse pattern (Fig. 3C, lower panel) .
Evaluation of keratinocyte-compatible media based on
StemPro in a scratch assay. To functionally assess the keratinocyte-compatible conditioned and dialyzed StemPro, this media was compared to high-calcium media (StemPro and conditioned StemPro) and low-calcium non-conditioned media (dialyzed StemPro and EpiLife) in a scratch assay (Fig. 4) . The conditioned and dialyzed StemPro increased the closure rate of the scratch when compared to the low-calcium nonconditioned media. The two low-calcium non-conditioned media (dialyzed StemPro and EpiLife) both supported healing of the scratch in a comparable manner. Furthermore, the results from the non-dialyzed StemPro media confirmed the unsuitability of using high-calcium media when assessing growth and migration of primary keratinocytes.
Effect of hypoxia on the wound healing properties of ASCs.
The dialyzed conditioned media derived from either ASCs cultured under either hypoxic or normoxic conditions was compared in the keratinocyte scratch assay. No differences between the media were observed with respect to the effect on cell morphology. However, it appeared that the closure of the scratch was more complete in the keratinocytes exposed to the media from ASCs cultured under hypoxic conditions (Fig. 5A ). For both types of media, the repopulation of the wound area occurred through cells migrating in an individual random pattern, rather than as linear fronts of the wound edge approximating one another. A quantification of the keratinocyte wound closure in the conditioned media compared to the closure in EpiLife, revealed that both normoxic and hypoxic conditioned media promoted wound closure to a greater extent than EpiLife (data not shown). Furthermore, it appeared that the media from the ASCs cultured under hypoxic conditions was consistently superior to that from the ASCs cultured under normoxic conditions, and this difference was statistically significant after 24 h (Fig. 5B) .
Discussion
For the development of a treatment for chronic wounds, it is apparent from animal experiments and small-scale clinical trials that ASCs harbor a significant potential for use in regenerative therapy (22) . To harness that potential, good in vitro models are warranted that enable the systematic analysis of the various wound healing properties of ASCs and how these properties may be enhanced.
In the present study, we described the modification of a scratch assay, such that an evaluation of the ASC secretome on wound healing properties of human primary keratinocytes could be carried out. To create a scratch assay that is compatible with both ASCs and primary keratinocytes, we tried a number of approaches. First, we explored whether both ASCs and keratinocytes could be cultured in either EpiLife or StemPro, The wound area was determined as the wound area at a given time relative to the original wound area. Data are presented as the means ± SEM. The dialyzed conditioned StemPro (StemPro CD) consistently supported wound healing better than EpiLife, and the difference in performance was statistically significant at 3 h after wounding (p<0.001) and onwards. Additionally, the non-dialyzed StemPro media performed worse than EpiLife, and this difference was statistically significant from 9 h after wounding (p<0.01, n= 6). ** p<0.01 and *** p<0.001.
such that the conditioned medium from the ASCs could be use directly on the keratinocytes. Since the ASCs did not proliferate in EpiLife, confirming previous observations of ASCs in keratinocyte media (23) and the keratinocytes differentiated in StemPro, this option was not viable. As the literature describes keratinocyte media to be low and mesenchymal stem cell media to be high in calcium (14), we speculated that the failure of either cell type to thrive in the medium developed for the other could be caused by different requirements for calcium.
A titration of calcium for both cell types confirmed this. The primary keratinocytes differentiated when exposed to even moderately higher calcium concentrations than those found in EpiLife, in agreement with what is already known (24) , and the ASCs cell number decreased when the calcium concentration was lower than that found in standard ASC media, possibly due to the influence of calcium on the cell adhesion to the substrate. Based on the incompatibility of the media with both cell types, several approaches were explored to decrease the calcium contribution from the conditioned StemPro. Simple dilution of StemPro with EpiLife (up to 1:3) did not decrease the calcium concentration sufficiently to avoid differentiation of the keratinocytes. Further dilution was not attempted due to the risk of attenuating the putative effect of the ASCs. Re-suspending a concentrated protein fraction of the conditioned StemPro in EpiLife was not a solution either, as the keratinocytes did not attach well in this media, possibly due to increases in osmolarity. When StemPro was dialyzed, a normal keratinocyte morphology was maintained. Furthermore, we observed that dialyzed StemPro and EpiLife supported keratinocyte migration in an equivalent manner. Thus, it is possible to assess the wound healing effects of ASCs in a scratch assay with primary keratinocytes, provided that the conditioned media is dialyzed.
When applying conditioned media from ASCs cultured under normoxic or hypoxic conditions, it was obvious that the ASCs secreted factors that promoted primary keratinocyte wound healing in vitro, and that this effect was enhanced by culturing the ASCs under hypoxic conditions. Our results are thus consistent with the findings of other studies, in that ASCs and other mesenchymal stem cells promote keratinocyte-based wound healing significantly (3, 8) . Furthermore, our findings indicated that this effect is also present when studying the more relevant primary human keratinocytes rather than immortalized cell lines. Of note, the random migratory pattern of the cells during wound closure could be an indication of the keratinocytes undergoing a epithelial-to-mesenchymal transition (25) .
In general, mesenchymal cells are known to provide a microenvironment that maintains the progenitor status of basal keratinocytes and augments epidermal proliferation, and mesenchymal cells are therefore commonly used as feeder cells in keratinocyte cultures (26) . In connection to this, ASCs, which are of mesenchymal origin, have been shown to secrete a plethora of growth factors, such as keratinocyte growth factor (KGF), EGF, bFGF, hepatocyte growth factor (HGF), and insulin-like growth factor-1 (IGF-1) (27) , which are key mediators of migration of human primary keratinocytes (28) . The secretion of these factors could provide part of the explanation for the effect of the conditioned medium on keratinocyte wound closure.
When using conditioned media from ASCs cultured under hypoxic conditions, an even more pronounced effect on the wound closure of the keratinocytes was observed. The exposure of ASCs to hypoxia has been shown to increase the secretion of a wide range of growth factors, signaling molecules and cytokines (29) . bFGF and IGF-1 are among these factors (30, 31) , and it is possible that these proteins play a role in the enhanced stimulatory effect of the hypoxic-conditioned ASCs. The majority of studies on the ASC secretome under hypoxic conditions have focused on a narrow range of proteins mostly involved in angiogenesis (2,4,16) , and not on global discovery-based approaches. To begin to unravel the molecular First, the wound closure was determined as the wound area at a given time relative to the original wound area, after which the relative wound closure was calculated as wound closure in conditioned medium divided by the wound closure in EpiLife. Data are presented as the means ± SEM (n= 6). The data from normoxic and hypoxic media was compared showing a statistical significant difference after 24 h, * p<0.01.
mechanisms underlying the wound healing effects of ASCs, we recently performed a proteomic profiling of ASCs exposed to hypoxia and normoxia, and found that several of the factors differentially regulated by hypoxia were involved in extracellular matrix (ECM) synthesis (32) . It will be interesting to determine whether the ECM-related proteins secreted by ASCs are responsible for the observed effects on the keratinocytes. The establishment of good wound models will support the translation of ASCs into clinical use, as they can play an important role both for the development and validation of novel protocols prior to embarking on large-scale clinical studies (33) . Additionally, the models may be used post-translationally to predict treatment outcome, so forth a correlation between the modeled parameter and the clinical outcome can be verified. Good wound models may thus facilitate the translation of regenerative ASC-based wound therapies into clinical practice.
